Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Published in: Indian Journal of Hematology and Blood Transfusion 1/2014

01-09-2014 | Case Report

Hyperleukocytosis in Newborn: A Diagnosis of Concern

Authors: Yusuf Parvez, Aji George Mathew

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2014

Login to get access

Abstract

Leukocytosis is well recognised in neonate; mostly it is physiological but the counts rarely exceed 30,000/mm3. Hyperleukocytosis defined as WBC count of more than 100,000 mm3 is rare and imposes a diagnostic challenge and should be investigated for leukaemia, leukocyte adhesion defect and myeloproliferative disorders. We report a classic case to highlight this entity.
Literature
1.
Sushanth, Avabratha KS, Tauro KJ, Shwethadri GK (2010) Hyperleukocytosis in a neonate: a diagnostic dilemma. Indian J Med Paediatr Oncol 31(3):86–88PubMedPubMedCentral
2.
Granger JM, Kontoyiannis DP (2009) Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study. Cancer 115(17):3919–3923PubMedCrossRef
3.
Alizadeh P, Rahbarimanesh AA, Bahram MG, Salmasian H (2007) Leukocyte adhesion deficiency type 1 presenting as leukemoid reaction. Indian J Pediatr 74(12):1121–1123PubMedCrossRef
4.
Wirbelauer J, Thomas W, Siauw C, Wössner R, Speer CP (2008) Leukemoid reaction in extremely immature preterm infants. Z Geburtshilfe Neonatol 212(5):165–169PubMedCrossRef
5.
Hsiao R, Omar SA (2005) Outcome of extremely low birth weight infants with leukemoid reaction. Pediatrics 116(1):e43–e51PubMedCrossRef
6.
Zwaan MC, Reinhardt D, Hitzler J, Vyas P (2008) Acute leukemias in children with down syndrome. Pediatric Clin North Am 55:53–70CrossRef
7.
Ishii E et al (2006) Features and outcome of neonatal leukemia in Japan: experience of the Japan infant leukemia study group. Pediatr Blood Cancer 47(3):234–235CrossRef
8.
Brown L, Shaw T, Wittlake WA (2005) Does leucocytosis identify bacterial infections in febrile neonates presenting to the emergency department? Emerg Med J 22(4):256–259PubMedCrossRefPubMedCentral
Metadata
Title
Hyperleukocytosis in Newborn: A Diagnosis of Concern
Authors
Yusuf Parvez
Aji George Mathew
Publication date
01-09-2014
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2014
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-013-0286-8

Other articles of this Special Issue 1/2014

Indian Journal of Hematology and Blood Transfusion 1/2014 Go to the issue

Case Report

Pancytopenia and Isolated Bone Marrow Recurrence in a Case of Previously Resected Gastric Carcinoma: A Rare Finding

Case Report

Burkittts Lymphoma Revisited: Series of Three Cases with Varied Clinical Presentation

Case Report

Pyrexia, Lung nodules, Granulomas: Pulmonary Lymphomatoid Granulomatosis

Case Report

Aberrant Immunophenotypic Expression of CD5 in a Case of B Acute Lymphoblastic Leukemia: A Case Report

Case Report

Hemophagocyte Lymphohistiocytosis Secondary to Bilateral Epididymal Diffuse Large B-Cell Lymphoma

Case Report

Granulocyte Colony Stimulating Factor Induced Sweet’s Syndrome Following Autologous Transplantation in a Child with Relapsed Acute Myeloblastic Leukemia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits